GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) » Definitions » Land And Improvements

Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Land And Improvements : ₫0.00 Mil (As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Pharbaco Central Pharmaceutical JSC No 1 Land And Improvements?

Pharbaco Central Pharmaceutical JSC No 1's land and improvements for the quarter that ended in . 20 was ₫0.00 Mil.


Pharbaco Central Pharmaceutical JSC No 1 Land And Improvements Historical Data

The historical data trend for Pharbaco Central Pharmaceutical JSC No 1's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharbaco Central Pharmaceutical JSC No 1 Land And Improvements Chart

Pharbaco Central Pharmaceutical JSC No 1 Annual Data
Trend
Land And Improvements

Pharbaco Central Pharmaceutical JSC No 1 Semi-Annual Data
Land And Improvements

Pharbaco Central Pharmaceutical JSC No 1 Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


Pharbaco Central Pharmaceutical JSC No 1 Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
160 Ton Duc Thang, Hang Bot ward, Dong Da District, Hanoi, VNM
Pharbaco Central Pharmaceutical JSC No 1 is a pharmaceutical company. Some of its products include Cefadroxil 250mg, Elnizol infusion drug, and Fabafixim 50.

Pharbaco Central Pharmaceutical JSC No 1 Headlines

No Headlines